Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Mindray Medical Beats Street

publication date: Aug 8, 2007
Guides Higher for Full-Year 2007 Mindray Medical (MR), based in Shenzhen but listed on the NYSE, reported second-quarter earnings per share that were 20% above analysts estimates. Its net for the period represented a 69% increase over the year-earlier quarter, with sales to international markets leading the surge. In response to the better than expected report, management raised its forecast slightly for full-year net income to 615 million RMB ($85 million), an increase of approximately 20 million RMB (the numbers are non-GAAP net). More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital